UBS Group’s Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share CLAA.WS Stock Holding History

UBS Group’s Portfolio CLAA.WS Stock Details CLAA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,469	Closed	–	–	11535
2022 Q3	$0	Hold	1,469	–	–	﹤0.01%	11457
2022 Q2	$0	Sell	1,469 -1	-0.1%	–	﹤0.01%	11438
2022 Q1	$1K	Sell	1,470 -199	-12%	-$100	﹤0.01%	10060
2021 Q4	$1K	Sell	1,669 -724	-30%	-$583	﹤0.01%	10127
2021 Q3	$2K	Buy	2,393 +2,143	+857%	+$2.02K	﹤0.01%	9054
2021 Q2	$0	Buy	+250	New	+$230	﹤0.01%	10069

Other funds holding CLAA.WS

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

PSAMP

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return

QGA

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

UBS Group's CLAA.WS Position: Q4 2022 in Review

UBS Group sold out of Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (CLAA.WS) in Q4 2022, closing a stake of 1,469 shares.

UBS Group first reported a position in CLAA.WS in Q2 2021 and held it in 6 quarters. The position peaked at $2K in Q3 2021. 42 funds tracked by Wall St. Rank hold CLAA.WS as of Q4 2022.

UBS Group reported no remaining Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
UBS Group sold 1,469 Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q4 2022.
UBS Group first reported a position in Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q2 2021 and held it in 6 quarters.
UBS Group's Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $2K in Q3 2021.
42 funds tracked by Wall St. Rank held Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.